切换至 "中华医学电子期刊资源库"
高级检索
中华结直肠疾病电子杂志

中华结直肠疾病电子杂志 ›› 2018, Vol. 07 ›› Issue (05) : 437 -441. doi: 10.3877/cma.j.issn.2095-3224.2018.05.006

所属专题： 文献；

论著

长非编码RNA H19在结直肠癌化疗敏感性中的作用研究
王秀梅1, 赵海平2,†(), 秦琼3, 刘永强4, 张兵2, 武永胜2   
  1. 1. 010020　呼和浩特，内蒙古自治区肿瘤医院&内蒙古医科大学附属人民医院肿瘤内科
    2. 010020　呼和浩特，内蒙古自治区肿瘤医院&内蒙古医科大学附属人民医院腹外科
    3. 017000　内蒙古鄂尔多斯达拉特旗人民医院肿瘤内科
    4. 010059　呼和浩特，内蒙古医科大学附属医院腹外科
  • 收稿日期:2017-09-17 出版日期:2018-10-25
  • 通信作者: 赵海平
  • 基金资助:
    内蒙古自治区肿瘤医院院内基金(No.2017066)

Role of long noncoding RNA H19 in chemosensitivity of colorectal cancer

Xiumei Wang1, Haiping Zhao2,†(), Qiong Qin3, Yongqiang Liu4, Bing Zhang2, Yongsheng Wu2   

  1. 1. Department of oncology, Inner Mongolia Cancer Hospital & Department of oncology, The Affiliated People′s Hospital of Inner Mongolia Medical University, Inner Mongolia 010020, China
    2. Department of General Surgery Inner Mongolia Cancer Hospital & Department of General Surgery, The Affiliated People′s Hospital of Inner Mongolia Medical University, Inner Mongolia 010020, China
    3. Department of Oncology, Inner Mongolia Ordos Dalad Banner People′s Hospital, Inner Mongolia 017000, China
    4. Department of General Surgery, The Affiliated People′s Hospital of Inner Mongolia Medical University, Inner Mongolia 010059, China
  • Received:2017-09-17 Published:2018-10-25
  • Corresponding author: Haiping Zhao
  • About author:
    Corresponding author: Zhao Haiping, Email:
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

王秀梅, 赵海平, 秦琼, 刘永强, 张兵, 武永胜. 长非编码RNA H19在结直肠癌化疗敏感性中的作用研究[J]. 中华结直肠疾病电子杂志, 2018, 07(05): 437-441.

Xiumei Wang, Haiping Zhao, Qiong Qin, Yongqiang Liu, Bing Zhang, Yongsheng Wu. Role of long noncoding RNA H19 in chemosensitivity of colorectal cancer[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2018, 07(05): 437-441.

目的

研究长非编码RNA H19在结直肠癌化疗药物敏感性中作用。

方法

分别构建lncRNA H19稳定过表达及表达沉默的结肠癌细胞株，分别加入5-FU培养，RT-qPCR检测H19表达，MTT法检测各组细胞增殖率，通过划痕实验检测各组迁移能力；Western blot检测各组细胞凋亡蛋白、耐药蛋白MDR1、MRP1和BCRP表达。

结果

与正常细胞比较，lncRNA H19在结直肠癌细胞中表达升高，lncRNA H19稳定过表达组细胞增殖率明显高于H19表达沉默组，lncRNA H19稳定过表达组细胞48 h迁移距离明显大于H19表达沉默组，lncRNA H19稳定过表达组Bax蛋白表达下调，BCL-2、MDR1、MRP1和BCRP表达上调，H19表达沉默组Bax蛋白表达上调，BCL-2、MDR1、MRP1和BCRP表达下调。

结论

lncRNA H19高表达的结直肠癌降低结直肠癌对化疗药物的敏感性，下调lncRNA H19表达可提高化疗药物的疗效。

关键词: 结直肠肿瘤, lncRNA H19, 化疗敏感性, 长链非编码RNA, 凋亡
Objective

To study the role of long non-coding RNA H19 in the chemosensitivity of colorectal cancer.

Methods

The colon cancer cell lines stably overexpressed and silenced with lncRNA H19 were constructed and cultured in 5-FU. The expression of H19 was detected by RT-qPCR. The cell proliferation rate was measured by MTT assay. The migration ability of each group was evaluated by scratch test. The protein expressions of MDR1, MRP1 and BCRP were detected by Western blot.

Results

Compared with normal cells, the expression of lncRNA H19 increased, and the proliferation rate of lncRNA H19 stable overexpression group was significantly higher than that of H19 silencing group. The migration distance in lncRNA H19 stable overexpression group was significantly longer than that in H19 silencing group and the overexpression of bcl-2 protein was down-regulated and bax、MDR1、MRP1 and BCRP was up-regulated in lncRNA H19 stable overexpression group. The expression of bcl-2 protein was up-regulated and the expression of bax、MDR1、MRP1 and BCRP was down-regulated in H19 silencing group.

Conclusion

Colorectal cancer with high expression of lncRNA H19 reduces the sensitivity of colorectal cancer to chemotherapeutic drugs, and down-regulation of lncRNA H19 expression can improve the curative effect of chemotherapy drugs.

Key words: Colorectal neoplasms, lncRNA H19, Chemosensitivity, Long Noncoding RNA, Apoptosis
图1 lncRNA H19在结直肠癌组织中高表达
图2 lncRNA H19转染
图3 结肠癌细胞株LoVo对5-FU的化疗敏感性
图4 各组细胞迁移水平
图5 蛋白表达印迹图
[1]
Siegel RL, Miller KD, Jemal A.Cancer statistics, 2015 [J]. CA Cancer J Clin，2016, 66(1):7-30
[2]
Song M, Garrett WS, Chan A. Nutrients, foods, and colorectal cancer prevention [J]. Gastroenterology, 2015, 148(6):1244-1260.
[3]
Boeckx N, Janssens K, Van Camp G, et al. The predictive value of primary tumor location in patients with metastatic colorectal cancer: A systematic review [J]. Crit Rev Oncol Hematol, 2018, 121:1-10.
[4]
Kunej T, Obsteter J, Pogacar Z, et al. The decalog of long non-coding RNA involvement in cancer diagnosis and monitoring [J]. Crit Rev Clin Lab Sci, 2014, 51(6):344-357.
[5]
Kunej T, Obsteter J, Pogacar Z, et al. The decalog of long non-coding RNA involvement in cancer diagnosis and monitoring [J]. Crit Rev Clin Lab Sci, 2014, 51(6):344-357.
[6]
Luo J, Qu J, Wu DK, et al. Long non-coding RNAs: a rising biotarget in colorectal cancer [J]. Oncotarget, 2017, 8(13):22187-22202.
[7]
Fanale D, Castiglia M1, Bazan V, et al. Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer [J]. Adv Exp Med Biol, 2016, 937:207-228.
[8]
Collette J, Le Bourhis X, Adriaenssens E. Regulation of Human Breast Cancer by the Long Non-Coding RNA H19 [J]. Int J Mol Sci, 2017, 18(11). pii:E2319.
[9]
王胜杰，翟从劼，姜霞, 等. 结直肠癌相关长链非编码RNA的研究进展 [J]. 山东医药, 2017, 57(24):97-99.
[10]
黄东宁，梁小娜.长链非编码RNA在结直肠癌中的研究进展 [J]. 实用肿瘤学杂志, 2015, 29(3):263-266.
[11]
Majidinia M, Yousefi B. Long non-coding RNAs in cancer drug resistance development [J]. DNA Repair (Amst), 2016, 45:25-33.
[12]
Cai X, Cullen BR.The imprinted H19 noncoding RNA is a primary microRNA precursor [J]. RNA.2007, 13(3):313-316.
[13]
Li H, Li J, Jia S, et al. miR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer [J]. Oncotarget, 2015, 6(31):31958-31984.
[14]
Tong M, Zheng W, Li H, et al. Multi-omics landscapes of colorectal cancer subtypes discriminated by an individualized prognostic signature for 5-fluorouracil-based chemotherapy [J]. Oncogenesis, 2016, 5(7):e242.
[15]
Li X, Cai H, Zheng W, et al. An individualized prognostic signature for gastric cancer patients treated with 5-Fluorouracil-based chemotherapy and distinct multi-omics characteristics of prognostic groups [J]. Oncotarget, 2016, 7(8):8743-8755.
[16]
Jo YK, Park NY, Shin JH, et al. Up-regulation of UVRAG by HDAC1 inhibition attenuates 5FU-induced cell death in HCT116 colorectal cancer cells [J]. Anticancer Res, 2018, 38(1):271-277.
[17]
Zhang X, Chen Y, Hao L, et al. Macrophages induce resistance to 5-fluorouracil chemotherapy in colorectal cancer through the release of putrescine [J]. Cancer Lett, 2016, 381(2):305-313.
[18]
Han D, Gao X, Wang M, et al. Long noncoding RNA H19 indicates a poor prognosis of colorectal cancer and promotes tumor growth by recruiting and binding to eIF4A3 [J]. Oncotarget, 2016, 7(16):22159-22173.
[1] 康夏, 田浩, 钱进, 高源, 缪洪明, 齐晓伟. 骨织素抑制破骨细胞分化改善肿瘤骨转移中骨溶解的机制研究[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 329-339.
[2] 代莉, 邓恢伟, 郭华静, 黄芙蓉. 术中持续输注艾司氯胺酮对腹腔镜结直肠癌手术患者术后睡眠质量的影响[J]. 中华普通外科学文献(电子版), 2023, 17(06): 408-412.
[3] 王得晨, 杨康, 杨自杰, 归明彬, 屈莲平, 张小凤, 高峰. 结直肠癌微卫星稳定状态和程序性死亡、吲哚胺2,3-双加氧酶关系的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 462-465.
[4] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[5] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[6] 李婷, 张琳. 血清脂肪酸代谢物及维生素D水平与结直肠癌发生的关系研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 661-665.
[7] 关旭, 王锡山. 基于外科与免疫视角思考结直肠癌区域淋巴结处理的功与过[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 448-452.
[8] 顾睿祈, 方洪生, 蔡国响. 循环肿瘤DNA检测在结直肠癌诊治中的应用与进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 453-459.
[9] 倪文凯, 齐翀, 许小丹, 周燮程, 殷庆章, 蔡元坤. 结直肠癌患者术后发生延迟性肠麻痹的影响因素分析[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 484-489.
[10] 范小彧, 孙司正, 鄂一民, 喻春钊. 梗阻性左半结肠癌不同手术治疗方案的选择应用[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 500-504.
[11] 黄怡诚, 陆晨, 孙司正, 喻春钊. 肝特异性转录因子FOXA2在人结直肠癌肝转移阶梯模型中的表达变化及其意义[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 396-403.
[12] 于迪, 于海波, 吴焕成, 李玉明, 苏彬, 陈馨. 发状分裂相关增强子1差异表达对胆固醇刺激下血管内皮细胞的影响[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(05): 264-270.
[13] 孙昕, 程海波, 沈卫星. 基于全转录组学探讨仙连解毒方治疗Ⅲ期结直肠癌患者的疗效机制[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 277-283.
[14] 邓世栋, 刘凌志, 郭大勇, 王超, 黄忠欣, 张晖辉. 沉默SNHG1基因对膀胱癌细胞增殖、凋亡、迁移和铁死亡的影响[J]. 中华临床医师杂志(电子版), 2023, 17(07): 804-811.
[15] 张敏洁, 张小杉, 段莎莎, 施依璐, 赵捷, 白天昊, 王雅晳. 氢气治疗心肌缺血再灌注损伤的作用机制及展望[J]. 中华临床医师杂志(电子版), 2023, 17(06): 744-748.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号